Biotech

All Articles

Turnstone lays off 60%, shakes up C-suite to stretch out money

.Turnstone Biologics is actually minimizing its own head count by 60% as well as shocking its C-suit...

Gilead quits on $15M MASH bet after weighing preclinical data

.In a year that has viewed an approval as well as a boating of readouts for metabolic dysfunction-as...

Texas biotech centers cancer treaty, pins wishes on being overweight

.Alaunos Rehabs is actually axing a deal along with Precigen, quiting licensing legal rights to a ta...

Capricor reveals more records for DMD therapy after triggering BLA

.Capricor Therapeutics is actually taking a triumph tour for their stage 2 Duchenne muscle dystrophy...

FDA places Kezar lupus trial in grip complying with 4 individual fatalities

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus test on hold after the biotech warn...

Phase 3 Academic Stone trial strikes SMA goal, delivering stock up 200%

.A phase 3 test of Academic Rock's back muscular degeneration (SMA) applicant has attacked its main ...

CAMP 4 is actually most recent to eye IPO, while Upstream point out $182M program

.RNA biotech CAMP4 Therapeutics has marked out prepare for a $67 million IPO, with inflammation-focu...

Galecto acquires leukemia medicine, goes down bone tissue cancer resource in pivot

.A year after the failing of an idiopathic lung fibrosis prospect sent Galecto on a hunt for salvati...

Judo throws down $100M to knock out kidney disease

.Taking the floor covering is actually Judo Bio, a promising biotech equipped with $100 million to c...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has settled CSPC Drug Group $one hundred million for a preclinical heart disease medici...